ストックスクリーナーアプリを入手
1.59
1.27%
0.02
アフターアワーズ：
1.59
前日終値:
$1.57
開ける：
$1.56
24時間の取引高:
111.38K
Relative Volume:
0.47
時価総額：
$89.99M
収益：
-
当期純損益:
$-131.52M
株価収益率:
-0.8933
EPS:
-1.78
ネットキャッシュフロー:
$-107.56M
1週間 パフォーマンス:
-1.85%
1か月 パフォーマンス:
+10.42%
6か月 パフォーマンス:
+65.68%
1年 パフォーマンス:
+32.50%
1日の値動き範囲:
$1.51
$1.64
1週間の範囲:
$1.47
$1.72
52週間の値動き範囲:
$0.6101
$1.91
Prelude Therapeutics Inc Stock (PRLD) Company Profile
名前
Prelude Therapeutics Inc
セクター
電話
(302) 467-1280
住所
175 INNOVATION BOULEVARD, WILMINGTON
PRLD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRLD
Prelude Therapeutics Inc
|
1.59 | 88.86M | 0 | -131.52M | -107.56M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Prelude Therapeutics Inc Stock (PRLD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-19 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-06-20 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2024-03-13 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-02-20 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-12-19 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-09-09 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-29 | 開始されました | Jefferies | Buy |
| 2022-03-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-02-28 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-10-08 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-07-27 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-04-26 | 開始されました | H.C. Wainwright | Buy |
| 2021-03-09 | 開始されました | Barclays | Overweight |
| 2020-11-20 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-10-20 | 開始されました | BofA Securities | Buy |
| 2020-10-20 | 開始されました | Goldman | Neutral |
| 2020-10-20 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Prelude Therapeutics Inc (PRLD) 最新ニュース
Prelude Therapeutics Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView
How to build a custom watchlist for Prelude Therapeutics Incorporated2025 Key Highlights & Smart Money Movement Alerts - newser.com
Is Prelude Therapeutics Incorporated stock supported by innovation pipelinePortfolio Value Report & AI Enhanced Trading Alerts - newser.com
Using flow based indicators on Prelude Therapeutics IncorporatedEarnings Risk Summary & Advanced Technical Analysis Signals - newser.com
Is Prelude Therapeutics Incorporated stock a defensive play in 2025July 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Pattern recognition hints at Prelude Therapeutics Incorporated upside2025 Major Catalysts & Real-Time Volume Spike Alerts - newser.com
Can Prelude Therapeutics Incorporated stock sustain free cash flow growthJuly 2025 Movers & Precise Swing Trade Entry Alerts - newser.com
Can Prelude Therapeutics Incorporated stock maintain operating marginsWeekly Profit Summary & Real-Time Buy Signal Notifications - newser.com
Exit strategy if you’re trapped in Prelude Therapeutics IncorporatedJuly 2025 Action & Risk Controlled Swing Trade Alerts - newser.com
How Prelude Therapeutics Incorporated stock performs in interest rate cyclesInflation Watch & Free Expert Verified Stock Movement Alerts - newser.com
Real time alert setup for Prelude Therapeutics Incorporated performanceInsider Selling & Free Daily Entry Point Trade Alerts - newser.com
What institutional flow reveals about Prelude Therapeutics IncorporatedJuly 2025 Outlook & Scalable Portfolio Growth Methods - newser.com
Will Prelude Therapeutics Incorporated stock deliver shareholder value2025 Top Decliners & Long-Term Safe Investment Plans - newser.com
Volume spikes in Prelude Therapeutics Incorporated stock – what they meanJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com
What sentiment indicators say about Prelude Therapeutics Incorporated stock2025 Short Interest & Community Trade Idea Sharing - newser.com
Is Prelude Therapeutics Incorporated stock supported by strong fundamentalsJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Real time pattern detection on Prelude Therapeutics Incorporated stock2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
What machine learning models say about Prelude Therapeutics IncorporatedJuly 2025 Short Interest & Accurate Buy Signal Alerts - newser.com
How moving averages guide Prelude Therapeutics Incorporated trading2025 Key Highlights & AI Forecast for Swing Trade Picks - newser.com
Published on: 2025-10-29 03:26:55 - newser.com
Published on: 2025-10-29 01:02:41 - newser.com
Prelude Therapeutics (PRLD) Price Target Increased by 23.81% to 4.42 - Nasdaq
How Prelude Therapeutics Incorporated stock reacts to oil pricesQuarterly Trade Report & Weekly Setup with High ROI Potential - newser.com
Published on: 2025-10-28 06:50:10 - newser.com
Prelude Therapeutics Advances with PRT7732 in Targeted Cancer Therapy - TipRanks
Published on: 2025-10-27 08:25:19 - newser.com
Prelude Therapeutics Inc (PRLD) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):